glp-1 receptor agonists effectiveness comparison Clinical efficacy results from clinical trials comparing different Research shows GLP-1 receptor agonist
Description
24 Patients had a mean age of 60 years, mean diabetes duration of 4 years, mean A1C of 6.99%, and BP 132/79 mmHg
Even the 4mg dose saw 61% and 44% losing 15 and 20% body weight respectively
doi:10.1161/CIRCULATIONAHA.122.059595 12
It has been demonstrated that ligand-activated GLP- 1 receptor interacts with the Gas subunit and activates adenylate cyclase to generate cAMP
Elective procedures: if daily dosing, DC on the day of surgery
